Person

Lisa D. Earnhardt

EVP AND GROUP PRESIDENT, Abbott Laboratories

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$15.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 7, 2025ABTSale200$136.65$27K
Mar 6, 2025ABTSale91,167$133.82$12.2M
May 7, 2024ABTSale22,852$106.25$2.4M
Mar 1, 2024ABTSale694$118.50$82K
Mar 1, 2023ABTSale943$100.70$95K
Mar 1, 2022ABTSale943$118.15$111K
Mar 1, 2021ABTSale943$120.61$114K
Jun 10, 2020ABTSale872$90.84$79K

SEC reporting-owner ID (CIK) 1530893 · all filings on EDGAR

Lisa D. Earnhardt (ABT) | USBoard